Status:

UNKNOWN

Assessment of Valproate on Ethanol Withdrawal

Lead Sponsor:

CAMC Health System

Conditions:

Alcohol Dependence

Alcohol Withdrawal Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Alcohol use disorder, or heavy drinking, is commonly seen in patients who present to trauma centers. These patients are at risk for Alcohol Withdrawal Syndrome (AWS), which is collection of symptoms t...

Detailed Description

Alcohol use disorder is a common comorbidity among trauma patients. This pre-existing condition is associated with Alcohol Withdrawal Syndrome (AWS) and frequently complicates the management of this p...

Eligibility Criteria

Inclusion

  • Admission to Trauma Services
  • Heavy drinkers based on social history
  • Men \<65 years: \> 4 drinks per day or 14 per week
  • Women: \> 3 drinks per day or 7 drinks per week
  • All adults \>65 years: \> 3 drinks per day or 7 drinks per week
  • Moderate or severe alcohol use disorder based on social history and DSM-5 criteria
  • Moderate: Presence of 4-5 symptoms based on social history
  • Severe: Presence of 6 symptoms based on social history

Exclusion

  • Intubated patients
  • Glasgow Coma Score \<8
  • Grade IV liver laceration or greater
  • Child-Pugh Class B or greater, history of cirrhosis, or cirrhosis identified by radiographic imaging upon admission
  • Transaminase (AST/ALT) elevation of ≥ 2x normal
  • Anticipated admission less than 72 hours
  • Levetiracetam administration for seizure prophylaxis secondary to a traumatic brain injury
  • Patient with VPA as home medication
  • Known allergy to VPA
  • Patients with pre-existing blood dyscrasias, i.e. thrombocytopenia (platelet count \< 50,000, etc)
  • Inability to obtain social history from patient, surrogate, family member or an individual deemed to be knowledgeable about the patient's social history
  • Pregnancy

Key Trial Info

Start Date :

July 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2020

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT03235531

Start Date

July 11 2017

End Date

January 1 2020

Last Update

August 1 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Charleston Area Medical Center, General Hospital, Level 1 Trauma Center

Charleston, West Virginia, United States, 25301

2

Charleston Area Medical Center

Charleston, West Virginia, United States, 25304

Assessment of Valproate on Ethanol Withdrawal | DecenTrialz